L-Alaninol

We are L-Alaninol CAS:2749-11-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:L-Alaninol
CAS.NO:2749-11-3
Molecular Formula: C3H9NO
Molecular Weight:75.10970
 
Synonyms:
(2S)-2-aminopropan-1-ol
1-Propanol, 2-amino-, (2S)-
2-AMINOPROPANOL
H-L-ALA-OL
(2S)-(+)-2-Aminopropan-1-ol
(2S)-2-Amino-1-propanol
Alaninol
(S)-2-Amino-1-propanol
(S)-2-Aminopropan-1-ol
L-ALANILOL
(S)-Alaninol
L-Ala-ol
(S)-(+)-2-Amino-1-propanol
H-ALANINOL
1-Propanol, 2-amino-, (S)-
H-ALA-OL
(S)-2-Amino-propan-1-ol
 
Physical and Chemical Properties:
Density: 0.965 g / mL at 25 ° C (lit.)
Boiling point: 72-73 ° C11 mm Hg (lit.)
Melting point: -2 ° C
Flash point: 145 ° F
Refractive index: n20 / D 1.450
 
Specification:
Appearance:Colorless viscous liquid
Purity:≥99%
Water:≤1.0%
Total impurity:≤1.0%
Single impurity: ≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:S-(+)-2-Amino-1-propanol is an aliphatic amino alcohol shown to induce an antiproliferative effect in B16 melanoma cells. S-(+)-2-Amino-1-propanol is used in the preparation of oxazolines which are often used as ligands in homogeneous catalysis.

L-Alaninol


Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.4-aminophenol Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said.2553-19-7;155684-44-9 He has been isolated since that time and will continue to remain isolated until cleared by public health officials. His few close contacts have been identified and are being monitored for any sign of symptoms.3196-15-4 “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.“CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.

Related Products
Product Name
Tris(2-chloroethyl) Phosphite View Details
1-Bromohexadecane View Details
4-Chloro-3-fluoronitrobenzene View Details
4-(Trifluoromethoxy)nitrobenzene manufacturer 2-Methoxy-5-Nitro-6-Picoline manufacturer Light Stabilizer 292 manufacturer 2-Acetyl-3,5-dimethylpyrazine manufacturer AMP manufacturer